The Centers for Disease Control and Prevention (CDC), Division of Strategic National Stockpile (DSNS) intends to issue a solicitation for the purchase of Pralidoxime CL 1GM/20ML INJ (Protopam Chloride 1 GM INJ SDV), National Drug Code (NDC) 60977-0141-01. CDC's mission is to promote the health and quality of life by preventing and controlling disease, injury, and disability. The mission of the Division of Strategic National Stockpile (DSNS) is to deliver critical medical assets to the site of a national emergency. DSNS achieves this mission by operating and maintaining the CDC Strategic National Stockpile (SNS). The DSNS provides technical assistance through guidance and training to state and local public health departments on how to receive, distribute, and dispense medical supplies. When SNS assets are combined with federal, state, and local technical expertise to manage and distribute assets efficiently, DSNS ensures that key medical supplies are available during emergencies.

The objective of this procurement is to obtain Pralidoxime CL 1GM/20ML INJ (Protopam Chloride 1 GM INJ SDV), National Drug Code (NDC) 60977-0141-01.

This requirement is for full and open competition under the North American Industrial Classification System (NAICS) code of 325414 - Biological Product (except Diagnostic) Manufacturing with a small business size standard of 1,250 employees. The resultant award is expected to be a single award, firm fixed price contract. The period of performance will be for twelve (12) months.

This notice is not a request for proposals. No response to this notice is requested or required. The solicitation will be posted on FedBizOpps on or about May 8, 2017. Interested parties must respond to the solicitation in order to be considered for award of any resultant contract. The government will not maintain a bidder's list for this procurement. Interested parties are responsible for monitoring FedBizOpps regularly for release of the solicitation and any amendments.

Bid Protests Not Available